Professor Cass Byrnes discusses the treatment of cystic fibrosis patients with a CFTR modulator, and the evidence for the use of Trikafta

    Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) is funded for people aged 6 years and above with cystic fibrosis (CF), subject to eligibility criteria. 

    Professor Cass Byrnes MBChB, FRACP, MD (Auckland), GCCE (New South Wales) is in the Paediatric Department of the University of Auckland and a Paediatric Respiratory Specialist at Starship Children's Health and Kidz First Hospital.

    Simplifying COPD Treatment – Associate Professor Rob Young

    Simplifying COPD Treatment

    GPCME, South

    Saturday August 10, 2019

    Presentation by:
    Associate Professor Robert Young
    Consultant Physician, Auckland Hospital

    In this Breakfast Symposium, Associate Professor Rob Young discusses the diagnosis of COPD and simplifying treatment in the New Zealand context. He also covers the benefits of dual bronchodilation, the place of inhaled corticosteroids and non-pharmacological treatment.

    ALK Mutated Lung Cancer: A Rare Subtype of Non-Small Cell Lung Cancer

    Dr Gareth Rivalland, Medical Oncologist, discusses ALK mutated lung cancer. He describes its characteristics, diagnosis and staging, and various treatment options.

     

    Gareth is a Medical Oncologist specialising in thoracic and skin cancers at Auckland City Hospital and Harbour Cancer Centre in Auckland.

    Asthma & Respiratory Foundation NZ Adult Asthma Guidelines: A Quick Reference Guide

    Presentation by:
    Professor Richard Beasley
    Physician at Wellington Regional Hospital, Director of the Medical Research Institute of New Zealand, and Professor of Medicine at Victoria University of Wellington. Adjunct Professor at the University of Otago and Visiting Professor, University of Southampton, United Kingdom.

    In this video podcast Professor Richard Beasley provides an outline of the NZ Adult Asthma Guidelines published in November 2016. The purpose of the Asthma Foundation of New Zealand Quick Reference Guide is to provide simple, practical, evidence-based recommendations for the diagnosis, assessment and management of asthma in adults in a quick reference format. Professor Beasley also focuses on the changes to the guidelines since they were last update in 2002.